Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2018 1
2022 1
2023 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study).
Kaneko Y, Kato M, Tanaka Y, Inoo M, Kobayashi-Haraoka H, Amano K, Miyata M, Murakawa Y, Yasuoka H, Hirata S, Tanaka E, Miyasaka N, Yamanaka H, Yamamoto K, Takeuchi T; SURPRISE study group. Kaneko Y, et al. Ann Rheum Dis. 2018 Sep;77(9):1268-1275. doi: 10.1136/annrheumdis-2018-213416. Epub 2018 May 31. Ann Rheum Dis. 2018. PMID: 29853455 Free PMC article. Clinical Trial.
Clinical symptoms of SARS-CoV-2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination-A prospective multicentre cohort of health professionals (SURPRISE study).
Kohler P, Babouee Flury B, Güsewell S, Egger T, Leal O, Brucher A, Lemmenmeier E, Meier Kleeb D, Möller JC, Ortner M, Rieder P, Ruetti M, Schmid HR, Stocker R, Vuichard-Gysin D, Speer O, Wiggli B, Besold U, McGeer A, Risch L, Friedl A, Schlegel M, Vernazza P, Kahlert CR, Kuster SP; SURPRISE Study Group. Kohler P, et al. Influenza Other Respir Viruses. 2023 Jun 19;17(6):e13167. doi: 10.1111/irv.13167. eCollection 2023 Jun. Influenza Other Respir Viruses. 2023. PMID: 37346094 Free PMC article.
Colonization with resistant bacteria in hospital employees: an epidemiological surveillance and typing study.
Badinski T, Seiffert SN, Grässli F, Babouee Flury B, Besold U, Betschon E, Biggel M, Brucher A, Cusini A, Dörr T, Egli A, Goppel S, Güsewell S, Keller J, von Kietzell M, Möller JC, Nolte O, Ortner M, Roloff T, Ruetti M, Schlegel M, Seth-Smith HMB, Stephan R, Stocker R, Vuichard-Gysin D, Willi B, Kuster SP, Kahlert CR, Kohler P; SURPRISE Study Group. Badinski T, et al. Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0098524. doi: 10.1128/aac.00985-24. Epub 2024 Sep 26. Antimicrob Agents Chemother. 2024. PMID: 39324817
Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
Babouee Flury B, Güsewell S, Egger T, Leal O, Brucher A, Lemmenmeier E, Meier Kleeb D, Möller JC, Rieder P, Rütti M, Schmid HR, Stocker R, Vuichard-Gysin D, Wiggli B, Besold U, McGeer A, Risch L, Friedl A, Schlegel M, Kuster SP, Kahlert CR, Kohler P; SURPRISE Study Group. Babouee Flury B, et al. PLoS Med. 2022 Nov 7;19(11):e1004125. doi: 10.1371/journal.pmed.1004125. eCollection 2022 Nov. PLoS Med. 2022. PMID: 36342956 Free PMC article.
Changing Clinical Characteristics according to Insulin Resistance and Insulin Secretion in Newly Diagnosed Type 2 Diabetic Patients in Korea.
Son JW, Park CY, Kim S, Lee HK, Lee YS; Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug Naïve Type 2 Diabetes Patients in Korea (SURPRISE) Study Group. Son JW, et al. Diabetes Metab J. 2015 Oct;39(5):387-94. doi: 10.4093/dmj.2015.39.5.387. Epub 2015 Oct 22. Diabetes Metab J. 2015. PMID: 26566496 Free PMC article.